Short interest in CARISMA Therapeutics Inc (NASDAQ:CARM) decreased during the last reporting period, falling from 568.41K to 537.68K. This put 1.61% of the company's publicly available shares short.

Short interest for CARISMA Therapeutics gives investors a sense of the degree to which investors are betting on the decline of CARISMA Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 401.92K shares traded per day, it would take 1.34 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.